CMSC

Multiple Sclerosis Treatment Calls for More Solutions

May 31, 2017

Video

John Dirk Nieland, PhD, associate professor in the Department of Health Science and Technology at Aalborg University in Denmark, discusses his research team's connection between MS and lipid metabolism, the importance of condition-inflicted models, and the encompassing nature of treating MS.

Ocrelizumab Serves as a "Foot in the Door" for PPMS Treatment

May 30, 2017

Video

Clyde Markowitz, MD, discusses how ocrelizumab, the most recent FDA-approved multiple sclerosis (MS) treatment, doesn't need to have "blockbuster" results to progress the state of MS treatment.

The Case Against Aggressive and Induction Therapy for Multiple Sclerosis

May 28, 2017

Article

"We shouldn't reject these hypotheses, we should seek more data on them.

John Dirk Nieland on Discovering Lipid Metabolism's Role in MS

May 28, 2017

Article

He and a Danish team believe they've found the cause of multiple sclerosis.

The Responsibility of Strong MS Treatment and Children Patients

May 27, 2017

Video

Brenda Banwell, MD, FAAP, FRCPC, Children's Hospital of Philadelphia's Neurology Division chief, talks about the cruciality of early diagnosing in pediatric multiple sclerosis patients, and how their best outcome is just being able to live a normal, everyday life.

Degenerative Conditions in Pediatric MS Worsened By Limited Case Studies

May 26, 2017

Video

Brenda Banwell, MD, FAAP, FRCPC, chief of Childrens Hospital of Philadelphia's Division of Neurology, speaks on new discoveries of pediatric MS at the annual 2017 Consortium of Multiple Sclerosis Centers (CMSC) in New Orleans.

Oral Molecule Trial Shows Promise in MS Relapse Reduction

May 26, 2017

Article

The multi-dosage longterm studies of Cladribine Tablets were shared at CMSC.

Alemtuzumab Improves RRMS Activity Over 6 Years, Study Says

May 26, 2017

Article

The study was a continuation of a 2-year alemtuzumab study versus interferon.

Jeffrey Cohen, MD, Discusses New MS Criteria

May 26, 2017

Video

The director of experimental therapeutics at the Mellen MS Center at the Cleveland Clinic shared what's shaping the soon-to-be-released update on the most recent 2010 diagnosing criteria at the 2017 Consortium of Multiple Sclerosis Centers.

Q&A: Fred Lublin, MD, on New MS Treatment, Combination Therapy, and Nervous System Repair

May 26, 2017

Article

The Mount Sinai Hospital neurology professor shares his thoughts on MS care.

x